West Michigan Advisors LLC Invests $306,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

West Michigan Advisors LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, Holdings Channel reports. The fund bought 515 shares of the biotechnology company’s stock, valued at approximately $306,000.

Other large investors have also added to or reduced their stakes in the company. Public Sector Pension Investment Board increased its holdings in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the last quarter. CIBC Asset Management Inc grew its position in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares in the last quarter. Axxcess Wealth Management LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $814,000. Soros Capital Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at approximately $630,000. Finally, Friedenthal Financial lifted its stake in Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after purchasing an additional 1,231 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares in the company, valued at $84,168,016.18. This trade represents a 1.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock valued at $5,631,561 over the last three months. Company insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a research report on Thursday. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $528.45 on Friday. The company has a market capitalization of $40.30 billion, a PE ratio of 136.55, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a fifty day moving average of $609.55 and a 200-day moving average of $524.28. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.